Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/SYNCOMF stock hub

NSE/SYNCOMF has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/SYNCOMFis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.8B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/SYNCOMF

In the news

Latest news · NSE/SYNCOMF

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E20.1

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC22

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/SYNCOMF market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

172

Groups with data

Currency

INR

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	744
Employees Change	-254%
Employees Change Percent	-25.45
Enterprise value	INR 12.4B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE312C01025
Last refreshed	2026-05-10
Market cap	INR 13.8B
Price	INR 14.76
Price currency	INR
Rev Per Employee	6,755,861.56x
Sector	Healthcare
Sic	2834
Symbol	nse/SYNCOMF
Website	https://www.syncomformulations.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.99%
EV Earnings	17.96x
EV/EBIT	18.31x
EV/EBITDA	17.1x
EV/Sales	2.46x
P/B ratio	3.65x
P/E ratio	20.05x
P/S ratio	2.75x
PE Ratio10 Y	27.82x
PE Ratio3 Y	37.33x
PE Ratio5 Y	36.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.45%
EBITDA Margin	14.4%
Gross margin	39.75%
Gross Profit	INR 2B
Gross Profit Growth	42.74%
Gross Profit Growth Q	32.36%
Gross Profit Growth3 Y	35.85%
Gross Profit Growth5 Y	24.85%
Net Income	INR 689.6M
Net Income Growth	76.16%
Net Income Growth Q	45.43%
Net Income Growth Quarters	7%
Net Income Growth Years	3%
Net Income Growth3 Y	61.55%
Net Income Growth5 Y	21.8%
Pretax Margin	18.05%
Profit Margin	13.72%
Profit Per Employee	INR 926,853
Profitable Years	20
Roa5y	5.28
Roe5y	12.11
ROIC	21.96
Roic5y	9.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-6.76%
Cagr3y	34.24%
EPS Growth	75.03
EPS Growth Q	64.29
EPS Growth Quarters	7
EPS Growth Years	2
EPS Growth3 Y	56.58
EPS Growth5 Y	16.52
Revenue Growth	28.65x
Revenue Growth Q	-9.72x
Revenue Growth Years	3x
Revenue Growth3 Y	31.41x
Revenue Growth5 Y	17.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 1.5B
Debt	INR 7M
Debt EBITDA	INR 0.01
Debt Equity	INR 0
Equity	INR 3.8B
Interest Coverage	98.45
Net Cash	INR 1.4B
Net Cash By Market Cap	INR 10.44
Net Cash Growth	85.7%
Net Debt EBITDA	INR -1.99
Net Debt Equity	INR -0.38
Tangible Book Value	INR 3.8B
Tangible Book Value Per Share	INR 4.1
WACC	8.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-6.76%
200-day SMA	15.1
3Y total return	141.97%
50-day SMA	12.77
50-day SMA vs 200-day SMA	50under200
All Time High	27.9
All Time High Change	-47.1%
All Time High Date	2024-09-10
All Time Low	4.6
All Time Low Change	220.87%
All Time Low Date	2023-03-29
ATR	0.62
Beta	0.76
Ch YTD	3.51
High	15.14
High52	23.49
High52 Date	2025-05-28
High52ch	-37.16%
Low	14.59
Low52	10.21
Low52 Date	2026-03-30
Low52ch	44.56%
Ma50ch	15.58%
Price vs 200-day SMA	-2.26%
RSI	64.31
RSI Monthly	50.15
RSI Weekly	53.05
Sharpe ratio	-0.17x
Sortino ratio	-0.1
Total Return	-0.65%
Tr YTD	3.51
Tr1m	20.49%
Tr1w	7.03%
Tr3m	8.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 676.3M
Operating Income Growth	67.29
Operating Income Growth Q	47.88
Operating Income Growth3 Y	82.75
Operating Income Growth5 Y	18.45
Operating margin	13.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	461,948,690%
Shares Insiders	41.75%
Shares Institutions	0.14%
Shares Qo Q	-10.86%
Shares Yo Y	0.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,067,997.65x
Bv Per Share	4.1
Ch1m	20.49
Ch1w	7.03
Ch1y	-6.76
Ch3m	8.13
Ch3y	142
Ch6m	-8.15
Change	-1.34%
Change From Open	-1.47
Close	14.96
Days Gap	0.13
Depreciation Amortization	47,736,750
Dollar Volume	29,599,157.9
Earnings Date	2026-05-30
EBIT	INR 676.3M
EBITDA	INR 724M
EPS	INR 0.7
F Score	2
Fiscal Year End	March
Founded	1,988
Graham Number	8.18012
Graham Upside	-44.58
Income Tax	INR 217.6M
Is Primary Listing	0
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Lynch Fair Value	INR 16.04
Lynch Upside	8.7
Ma150	14.23
Ma150ch	3.72%
Ma20	13.88
Ma20ch	6.31%
Next Earnings Date	2026-05-30
Open	14.98
Position In Range	30.91
Price Date	2026-05-08
Price EBITDA	INR 19.1
Ptbv Ratio	3.65
Relative Volume	0.93x
Revenue	5,026,361,000x
Tax By Revenue	4.33x
Tax Rate	23.99%
Tr6m	-8.15%
Volume	2,005,363

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/SYNCOMF pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/SYNCOMF stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/SYNCOMF?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

+41.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.6%

Negative means the company is buying back shares.

Technical

NSE/SYNCOMF momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.3

Neutral momentum band

Price vs 200-day MA

-2.3%

50/200-day relationship not available

Beta (5Y)

0.76

Less volatile than the market

Sharpe ratio

-0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/SYNCOMF

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/SYNCOMF stock rating?

nse/SYNCOMF is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/SYNCOMF analysis?

The full report lives at /stocks/nse/SYNCOMF/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/SYNCOMF?

The latest report frames nse/SYNCOMF around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/SYNCOMF page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.